Devices & Neurotechnology
Details checkedClinical trial listing onlyHistorical/discontinuedCheckedregistry

Internet and Smartphone Tinnitus Retraining Therapy Study

Also known as: Ginkgo biloba, Modified TRT, App-delivered tinnitus retraining therapy

Institution-led study

Primary source
Sponsor / Institution
Institution-led study
Program Type
Software/Neurotech
Modality
Digital Therapeutic
Stage
Interventional/NA
Status
Discontinued
Target Gene
Route / Mode
Web and smartphone app plus oral comparator
Confidence
72%
Status Confidence
Status needs checking
Evidence Strength
Needs more support
Last Reviewed
2026-06-10
Geography
South Korea
Population
adult, tinnitus, digital-health, study-level
Trial IDs
1
Mechanism

Withdrawn hospital-led study comparing ginkgo biloba alone with ginkgo biloba plus modified tinnitus retraining therapy delivered through smartphone and web-based materials.

Indications
Notes

The source trial is not a standalone ginkgo product record. ClinicalTrials.gov verifies a withdrawn study of internet/smartphone-delivered tinnitus retraining therapy added to ginkgo biloba, so HearScape places it in the software/neurotech side rather than the therapeutic drug silo.

Evidence & Sources
1 structured sources
clinicaltrials
Supports: canonicalName, aliases, company, allCompanies, isIndustrySponsored, programType, modality, mechanism...
IDs: NCT01663467
Open
Key Events
Clinical Trials (1)
Data Checks
institution-led-studyregistry-verified-studydiscontinued-registry-studywas-therapeutic-misclassificationstudy-level-not-standalone-productnot-commercial-pipeline-program
Related Programs